Theravance Biopharma Inc TBPH
17.03 USD 0.00 (+0.00%)
At closeSep 23, 2026, 4:00 PM EDT
17.63 +0.60 +3.52%
After hours · Sep 23, 4:00 PM ET
17.02 Day range 17.07
13.08 52-week range 21.03
- YTD
- -8.98%
- 1 year
- +58.71%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 107.46M | 64.38M | 57.42M | 51.35M | 55.31M | |
| 107.46M | 64.38M | 57.42M | 51.35M | 55.31M | |
| -3.60M | -46.95M | -56.03M | -91.96M | -257.78M | |
| 105.89M | -56.42M | -55.19M | 872.13M | -199.43M | |
| 2.06 | -1.15 | -1.00 | 11.85 | -2.87 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 168.64M | 38.63M | 40.38M | 299.01M | 90.80M | |
| 485.57M | 354.16M | 382.00M | 607.40M | 374.82M | |
| 188.85M | 178.62M | 169.00M | 165.60M | 713.39M | |
| 42.70M | 49.82M | 49.16M | 52.16M | 669.52M | |
| 296.72M | 175.54M | 213.00M | 441.80M | -338.57M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 238.54M | -11.54M | -27.00M | -186.99M | -207.86M | |
| -105.28M | 12.28M | -32.70M | 1.15B | 124.49M | |
| -3.25M | -2.50M | -198.93M | -758.81M | 91.86M | |
| -42.00K | -332.00K | -975.00K | 1.29M | -3.40M | |
| 130.01M | -1.75M | -258.63M | 208.21M | 8.50M |